Search Results - "BASTELICA, D"

C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet by Poggi, M, Bastelica, D, Gual, P, Iglesias, M. A, Gremeaux, T, Knauf, C, Peiretti, F, Verdier, M, Juhan-Vague, I, Tanti, J. F, Burcelin, R, Alessi, M. C

“…Aims/hypothesis Inflammation is associated with obesity and has been implicated in the development of diabetes and atherosclerosis. During gram-negative…”
Get full text

Systemic inhibition and liver‐specific over‐expression of PAI‐1 failed to improve survival in all‐inclusive populations or homogenous cohorts of CLP mice by Raeven, P., Drechsler, S., Weixelbaumer, K. M., Bastelica, D., Peiretti, F., Klotz, A., Jafarmadar, M., Redl, H., Bahrami, S., Alessi, M. C., Declerck, P. J., Osuchowski, M. F.

“…Summary Background The role of plasminogen activator inhibitor type‐1 (PAI‐1) in abdominal sepsis remains elusive. Objectives To study the influence of…”
Get full text

Plasminogen activator inhibitor 1, transforming growth Factor-β1, and BMI are closely associated in human adipose tissue during morbid obesity by ALESSI, M.-C, BASTELICA, D, MORANGE, P, BERTHET, B, LEDUC, I, VERDIER, M, GEEL, O, JUHAN-VAGUE, I

Get full text

CD28 deletion improves obesity-induced liver steatosis but increases adiposity in mice by Poggi, M, Morin, S O, Bastelica, D, Govers, R, Canault, M, Bernot, D, Georgelin, O, Verdier, M, Burcelin, R, Olive, D, Alessi, M-C, Peiretti, F, Nunès, J A

“…Background/objectives: Lymphocytes have a critical role in visceral adipose tissue (AT) inflammation. The CD28 costimulatory molecule is required for…”
Get full text

Progression of atherosclerosis in ApoE-deficient mice that express distinct molecular forms of TNF-alpha by Canault, M, Peiretti, F, Poggi, M, Mueller, C, Kopp, F, Bonardo, B, Bastelica, D, Nicolay, A, Alessi, M.C, Nalbone, G

“…TNFα (TNF) critically regulates inflammation-driven atherosclerosis. Because the transmembrane (tmTNF) and soluble (sTNF) forms of TNF possess distinct…”
Get full text

Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss by MAVRI, A, ALESSI, M. C, BASTELICA, D, GEEL-GEORGELIN, O, FINA, F, SENTOCNIK, J. T, STEGNAR, M, JUHAN-VAGUE, I

“…Abdominal fat produces plasminogen activator inhibitor-1 (PAI-1) and could contribute to increased plasma PAI-1 values in human obesity associated with insulin…”
Get full text

Chronic plasminogen activator inhibitor‐1 (PAI‐1) overexpression dampens CD25+ lymphocyte recruitment after lipopolysaccharide endotoxemia in mouse lung by POGGI, M., PAULMYER‐LACROIX, O., VERDIER, M., PEIRETTI, F., BASTELICA, D., BOUCRAUT, J., LIJNEN, H. R., JUHAN‐VAGUE, I., ALESSI, M. C.

“…Background: Plasma plasminogen activator inhibitor‐1 (PAI‐1) level rises during sepsis and confers a worse prognosis. PAI‐1 participation to sepsis has been…”
Get full text

Influence of t-pA and u-PA on adipose tissue development in a murine model of diet-induced obesity by Morange, P E, Bastelica, D, Bonzi, M F, Van Hoef, B, Collen, D, Juhan-Vague, I, Lijnen, H R

“…To investigate the potential role of tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA) in development of adipose tissue,…”
Get more information

B010 Inhibition of furin by PAI-1: a potential role in metabolic syndrome by Bernot, D, Hadadeh, O, Bastelica, D, Nalbone, G, Alessi, M.-C, Peiretti, F

“…Metabolic Syndrome (MS) predisposes to type 2 diabetes (T2D) and coronary heart disease (CAD). Elevated levels of the serpin PAI-1 are observed in MS, and…”
Get full text

O79 Rôle du CD28 dans le développement de l’état inflammatoire et des complications métaboliques associés à l’obésité by Poggi, M, Morin, S, Favre, C, Giroux, V, Bastelica, D, Bernot, D, Georgelin, O, Verdier, M, Olive, D, Peiretti, F, Malissen, M, Nunes, J, Alessi, M.-C

“…Rationnel Le lymphocyte T (LyT) participe à l’inflammation du tissu adipeux (TA) Son activation fait intervenir le système de costimulation CD28/B7. La…”
Get full text

Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity by Alessi, M C, Bastelica, D, Morange, P, Berthet, B, Leduc, I, Verdier, M, Geel, O, Juhan-Vague, I

“…Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. M C Alessi ,…”
Get full text

Plasma PAI-1 Levels Are More Strongly Related to Liver Steatosis Than to Adipose Tissue Accumulation by Alessi, Marie-Christine, Bastelica, Delphine, Mavri, Alenka, Morange, Pierre, Berthet, Bruno, Grino, Michel, Juhan-Vague, Irene

“…OBJECTIVE—Because obesity and insulin resistance (IR) are strongly associated with liver steatosis (LS), we investigated the relation between the degree of LS…”
Get full text

Stromal Cells Are the Main Plasminogen Activator Inhibitor-1-Producing Cells in Human Fat: Evidence of Differences Between Visceral and Subcutaneous Deposits by Bastelica, Delphine, Morange, Pierre, Berthet, Bruno, Borghi, Hélène, Lacroix, Odile, Grino, Michel, Juhan-Vague, Irène, Alessi, Marie-Christine

“…Elevated plasma plasminogen activator inhibitor (PAI)-1 observed during insulin resistance has been connected with an excessive PAI-1 adipose tissue secretion…”
Get full text

ID: 282 PAI-1 modulates the inflammatory response during Lipopolysaccharide (LPS)-induced endotoxemia by Poggi, M., Paulmyer-Lacroix, O., Boucraut, J., Bastelica, D., Peiretti, F., Verdier, M., Lijnen, H., Juhan-Vague, I., Alessi, M.

Get full text

Adipose tissue and atherothrombosis by Alessi, Marie-Christine, Lijnen, H Roger, Bastelica, Delphine, Juhan-Vague, Irene

“…Obesity is associated with increased cardiovascular mortality and morbidity mainly through insulin resistance. Dysregulation of protein secretion by adipose…”
Get more information

B010 Inhibition of furin by PAI-1: a potential role in metabolic syndrome by Bernot, D., Hadadeh, O., Bastelica, D., Nalbone, G., Alessi, M.-C., Peiretti, F.

Get full text